drug resistance

Open Access
Targeting Glypican-1 Reverses Resistance to 5-Fluorouracil in Esophageal Adenocarcinoma Cells
AKSHAY PRATAP, ANDREA QUALMAN, HEDLUND GARRETT, ERLINDA THE, ARGUDIT CHAUHAN, JUAN P. IDROVO, LINLING CHENG, SACHIN WANI, ROBERT ALEXANDER MEGUID and XIANZHONG MENG

Anticancer Research August 2023, 43 (8) 3411-3418; DOI: https://doi.org/10.21873/anticanres.16516
You have access
Acquired AKT-inhibitor Resistance Is Mediated by ATP-binding Cassette Transporters in Endometrial Carcinoma
SHOJI TAKAGI, TAKAFUMI ONISHI, TSUYOSHI TAKASHIMA, KAZUKI SHIBAHARA and MICHIHIRO MORI

Anticancer Research June 2023, 43 (6) 2501-2507; DOI: https://doi.org/10.21873/anticanres.16417
You have access
ALCAM, Activated Leukocyte Cell Adhesion Molecule, in Clinical Gastric Cancer and Patient’s Response to Chemotherapies
YI MING YANG, FIONA RUGE, KE JI, SHUQIN JIA, YONGNING JIA, ANDREW J. SANDERS, JIAFU JI and WEN G. JIANG

Anticancer Research April 2023, 43 (4) 1463-1475; DOI: https://doi.org/10.21873/anticanres.16295
You have access
Experimental Exploration for Genes Related to Susceptibility and Resistance to Irinotecan
SUGURU OGATA, TOMOYA SUDOU, FUMIHIKO FUJITA, TAKEFUMI YOSHIDA, KENICHI KOUSHI, TAKASHI NOGUCHI, JUNYA FUKUDA, NANAE OGATA, YOSHITAKA NOBUKUNI and YOSHITO AKAGI

Anticancer Research August 2022, 42 (8) 4011-4016; DOI: https://doi.org/10.21873/anticanres.15897
You have access
Targeted Treatment of HPV16-positive and -negative SCC Cells With Small Molecule Tyrosine Kinase Inhibitors and Everolimus Affects MMP2 and MMP14 Expression
LENA HUBER, RICHARD BIRK, MANUEL KNUETTEL, NICOLE ROTTER, CHRISTOPH ADERHOLD, CLAUDIA SCHERL, ANNE LAMMERT, FREDERIC JUNGBAUER and BENEDIKT KRAMER

Anticancer Research July 2022, 42 (7) 3403-3411; DOI: https://doi.org/10.21873/anticanres.15827
You have access
Comparative Proteomic Profiling of Cisplatin-resistant Nasopharyngeal Carcinoma Cell Lines: Novel Biomarkers for Improving Chemotherapy of NPC
PARISA PRATHAPHAN, ONRAPAK REAMTONG, UTAPIN NGAOKRAJANG, TAVAN JANVILISRI, NAPACHANOK MONGKOLDHUMRONGKUL SWAINSON and PICHAMON KIATWUTHINON

Anticancer Research July 2022, 42 (7) 3507-3522; DOI: https://doi.org/10.21873/anticanres.15837
You have access
Co-treatment of Low Dose Pacritinib, a Phase III Jak2 Inhibitor, Greatly Increases Apoptosis of P-gp Over-expressing Cancer Cells With Multidrug Resistance
YUNMOON OH, JIN-SOL LEE, JI SUN LEE, JAE HYEON PARK, HYUNG SIK KIM and SUNGPIL YOON

Anticancer Research May 2022, 42 (5) 2433-2442; DOI: https://doi.org/10.21873/anticanres.15722
You have access
Circulating Tumor Cells Derived from Advanced Hepatocellular Carcinoma Rapidly Develop Resistance to Cytotoxic Chemotherapy
CHIA-HSUN HSIEH, CHAU-TING YEH, YA-HUI HUANG and MING-WEI LAI

Anticancer Research May 2022, 42 (5) 2479-2486; DOI: https://doi.org/10.21873/anticanres.15726
You have access
Ko143 Reverses MDR in Glioblastoma via Deactivating P-Glycoprotein, Sensitizing a Resistant Phenotype to TMZ Treatment
SAMUEL D. LUSTIG, SRAVAN K. KODALI, SHARON L. LONGO, SOMANATH KUNDU and MARIANO S. VIAPIANO

Anticancer Research February 2022, 42 (2) 723-730; DOI: https://doi.org/10.21873/anticanres.15530
You have access
Cholesterol Depletion Modulates Drug Resistance Pathways to Sensitize Resistant Breast Cancer Cells to Tamoxifen
GABRIELLA BIANCA HENRIQUES PALMA and MANDEEP KAUR

Anticancer Research January 2022, 42 (1) 565-579; DOI: https://doi.org/10.21873/anticanres.15514

Main menu

User menu

Search

drug resistance

Pages